Click image to view original image
1. Quick Detail:
|
Product Name |
Anastrozole |
|
Alias |
Arimidex,Tablets |
|
CAS |
120511-73-1 |
|
Assay |
98.0% |
|
Appearance |
White Crystalline Powder |
|
Molecular Formula |
C17H19N5 |
|
Molecular weight |
293.37 |
|
Grade |
Pharmaceutical Grade |
Description:
Anastrozole (marketed under the trade name Arimidex by AstraZeneca) is a non-steroidal aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and post-menopausalwomen. The severity of breast cancer can be increased by estrogen, as sex hormones cause hyperplasia, anddifferentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen. The patent on Arimidex by AstraZeneca expired June 2010.
Contact Person: Jack
Skype: PharChemSteroid
Email: jack@chembj.com
WhatsApp: +8617327096097
